Literature DB >> 25613907

Remote ischemic preconditioning and incidence of postoperative atrial fibrillation.

Lars Erik Berg Krogstad1, Katrine Hordnes Slagsvold, Alexander Wahba.   

Abstract

OBJECTIVES: Although remote ischemic preconditioning (RIPC) has shown favorable effects on ischemia-reperfusion injury, much remains unknown of its mechanisms and clinical significance. We hypothesized that RIPC would reduce the incidence of postoperative atrial fibrillation (POAF) following coronary artery bypass graft (CABG) surgery. In addition, we investigated whether RIPC could induce alterations of circulating microRNA in blood plasma.
DESIGN: This is a single-center, double-blind, randomized controlled trial. 92 adult patients referred for first-time isolated CABG surgery were randomly assigned to either RIPC (n = 45) or control (n = 47). The RIPC-stimulus comprised three 5-min cycles of upper arm ischemia, induced by inflating a blood pressure cuff to 200 mmHg, with an intervening 5 min reperfusion. Heart rhythm was assessed by telemetry. MicroRNA expression was assessed in plasma by real-time polymerase chain reaction.
RESULTS: Of the 92 patients included in the study, 27 patients developed POAF (29%). 17 of these patients belonged to the RIPC group (38%), and 10 to the control group (21%). There were no significant alterations of microRNA expression.
CONCLUSIONS: We did not observe a reduced incidence of POAF by RIPC before CABG surgery. Larger multi-center studies may be necessary to further clarify this issue.

Entities:  

Keywords:  coronary artery bypass; ischemic preconditioning; postoperative period; preoperative care

Mesh:

Substances:

Year:  2015        PMID: 25613907     DOI: 10.3109/14017431.2015.1010565

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  7 in total

Review 1.  Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).

Authors:  Carina Benstoem; Christian Stoppe; Oliver J Liakopoulos; Julia Ney; Dirk Hasenclever; Patrick Meybohm; Andreas Goetzenich
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

2.  Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside.

Authors:  Quintin J Quinones; Jerrold H Levy
Journal:  Anesth Analg       Date:  2018-02       Impact factor: 5.108

Review 3.  MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.

Authors:  Nicoline W E van den Berg; Makiri Kawasaki; Wouter R Berger; Jolien Neefs; Eva Meulendijks; Anke J Tijsen; Joris R de Groot
Journal:  Cardiovasc Drugs Ther       Date:  2017-06       Impact factor: 3.727

4.  Randomized controlled trial of remote ischemic preconditioning and atrial fibrillation in patients undergoing cardiac surgery.

Authors:  Amir S Lotfi; Hossein Eftekhari; Auras R Atreya; Ananth Kashikar; Senthil K Sivalingam; Miguel Giannoni; Paul Visintainer; Daniel Engelman
Journal:  World J Cardiol       Date:  2016-10-26

Review 5.  RNAs and Gene Expression Predicting Postoperative Atrial Fibrillation in Cardiac Surgery Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Muhammad Shuja Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Derek James Dosdall
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

Review 6.  Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.

Authors:  Muntasir Billah; Anisyah Ridiandries; Usaid Allahwala; Harshini Mudaliar; Anthony Dona; Stephen Hunyor; Levon M Khachigian; Ravinay Bhindi
Journal:  Oncotarget       Date:  2019-01-04

7.  Remote ischemic preconditioning and its role in the prevention of new onset atrial fibrillation post-cardiac surgery. A meta-analysis of randomized control trials.

Authors:  Ashish Kumar; Harpreet Singh; Mariam Shariff
Journal:  J Arrhythm       Date:  2019-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.